{"transactions":[{"id":1015750,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"President, CEO, COB"}}],"security":"Warrant","published_at":"2025-10-20T12:02:27.000Z","date":"2025-10-06","kind":"grant","planned":false,"acquired":true,"shares":11719,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":11719,"derivative":{"exercise_price":2.75,"exercise_date":"2026-04-08","expiration_date":"2030-10-08","underlying":"Common Stock","underlying_shares":11719},"source":{"system":"sec-edgar","filing":"0001021771-25-000140","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000102177125000140/form4.xml","form_type":"4"}},{"id":1015749,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"President, CEO, COB"}}],"security":"Common Stock","published_at":"2025-10-20T12:02:27.000Z","date":"2025-10-06","kind":"grant","planned":false,"acquired":true,"shares":15625,"price":1.6,"value":25000.0,"ownership":{"direct":true},"balance_after":187497,"source":{"system":"sec-edgar","filing":"0001021771-25-000140","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000102177125000140/form4.xml","form_type":"4"}},{"id":1258920,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"officer_title":"President, CEO, COB"}}],"security":"Stock Option","published_at":"2025-02-19T21:22:47.000Z","date":"2025-02-14","kind":"grant","planned":false,"acquired":true,"shares":791885,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options vests and becomes exercisable to the extent of 395,943 shares on February 14, 2025 and 395,942 shares in eight nearly equal quarterly installments beginning February 14, 2026 and continuing every three months thereafter until fully vested."}],"balance_after":791885,"derivative":{"exercise_price":2.46,"expiration_date":"2035-02-14","underlying":"Common Stock","underlying_shares":791885},"source":{"system":"sec-edgar","filing":"0001021771-25-000036","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000102177125000036/form4.xml","form_type":"4"}},{"id":1565749,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"officer_title":"President, CEO, COB"}}],"security":"Common Stock","published_at":"2024-03-20T20:36:08.000Z","date":"2024-03-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":17633,"price":1.39,"value":24509.87,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were withheld from vested stock grant to pay the associated withholding taxes."}],"balance_after":171872,"source":{"system":"sec-edgar","filing":"0001021771-24-000077","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000102177124000077/form4.xml","form_type":"4"}},{"id":1640653,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"President, CEO, COB"}}],"security":"Stock Option","published_at":"2024-02-15T21:11:35.000Z","date":"2024-02-13","kind":"grant","planned":false,"acquired":true,"shares":438596,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vests and becomes exercisable to the extent of 219,298 shares on February 13, 2024 and 219,298 shares in eight nearly equal quarterly installments beginning February 13, 2025 and continuing every three months thereafter until fully vested."}],"balance_after":438596,"derivative":{"exercise_price":1.45,"expiration_date":"2034-02-13","underlying":"Common Stock","underlying_shares":438596},"source":{"system":"sec-edgar","filing":"0001021771-24-000044","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000102177124000044/form4.xml","form_type":"4"}},{"id":1778680,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"President, CEO, COB"}}],"security":"Common Stock","published_at":"2023-09-18T13:17:53.000Z","date":"2023-09-15","kind":"purchase","planned":false,"acquired":true,"shares":2200,"price":1.7,"value":3740.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $1.66 to $1.75 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 48,912 shares received pursuant to an unvested restricted stock unit grant. Such shares vest on March 18, 2024."}],"balance_after":189505,"source":{"system":"sec-edgar","filing":"0001021771-23-000096","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000102177123000096/form4.xml","form_type":"4"}},{"id":1781835,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"President, CEO, COB"}}],"security":"Common Stock","published_at":"2023-09-13T21:00:12.000Z","date":"2023-09-13","kind":"purchase","planned":false,"acquired":true,"shares":800,"price":1.5325,"value":1226.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $1.52 to $1.54 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 48,912 shares received pursuant to an unvested restricted stock unit grant. Such shares vest on March 18, 2024."}],"balance_after":188105,"source":{"system":"sec-edgar","filing":"0001021771-23-000090","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000102177123000090/form4.xml","form_type":"4"}},{"id":1786786,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"President, CEO, COB"}}],"security":"Common Stock","published_at":"2023-09-06T21:53:45.000Z","date":"2023-09-06","kind":"purchase","planned":false,"acquired":true,"shares":2887,"price":1.96,"value":5658.52,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $1.93 to $2.02 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 48,912 shares received pursuant to an unvested restricted stock unit grant. Such shares vest on March 18, 2024."}],"balance_after":187305,"source":{"system":"sec-edgar","filing":"0001021771-23-000088","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000102177123000088/form4.xml","form_type":"4"}},{"id":1823407,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"President, CEO, COB"}}],"security":"Common Stock","published_at":"2023-07-25T21:56:48.000Z","date":"2023-07-25","kind":"purchase","planned":false,"acquired":true,"shares":4200,"price":2.44,"value":10248.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $2.41 to $2.47 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 48,912 shares received pursuant to an unvested restricted stock unit grant. Such shares vest on March 18, 2024."}],"balance_after":184418,"source":{"system":"sec-edgar","filing":"0001140361-23-036103","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000114036123036103/form4.xml","form_type":"4"}},{"id":1941302,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"President, CEO, COB"}}],"security":"Common Stock","published_at":"2023-03-22T20:47:23.000Z","date":"2023-03-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":6729,"price":2.92,"value":19648.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were withheld from vested stock grant to pay the associated withholding taxes."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 48,912 shares received pursuant to an unvested restricted stock unit grant.  Such shares vest on March 18, 2024."}],"balance_after":180218,"source":{"system":"sec-edgar","filing":"0001021771-23-000026","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000102177123000026/form4.xml","form_type":"4"}},{"id":1989814,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President, CEO, COB"}}],"security":"Common Stock","published_at":"2023-02-27T22:17:21.000Z","date":"2023-02-18","kind":"tax_withholding","acquired":false,"shares":374,"price":2.99,"value":1118.26,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were withheld from vested stock grant to pay the associated withholding taxes."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 98,862 shares received pursuant to an unvested restricted stock unit grant. Such shares vest to the extent of 49,949 shares on March 18, 2023 and 48,913 shares on March 18, 2024."}],"balance_after":186947,"source":{"system":"sec-edgar","filing":"0001567619-23-003875","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761923003875/doc1.xml","form_type":"4"}},{"id":2006688,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President, CEO, COB"}}],"security":"Stock Option","published_at":"2023-02-17T22:27:27.000Z","date":"2023-02-17","kind":"grant","acquired":true,"shares":106762,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests and becomes exercisable to the extent of 53,381 shares on February 17, 2023 with the remaining 53,381 shares vesting in eight nearly-equal quarterly installments beginning on February 17, 2024 and continuing every three months thereafter until fully vested."}],"balance_after":106762,"derivative":{"exercise_price":2.91,"expiration_date":"2033-02-17","underlying":"Common Stock","underlying_shares":106762},"source":{"system":"sec-edgar","filing":"0001567619-23-003324","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761923003324/doc1.xml","form_type":"4"}},{"id":2035338,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, COB"}}],"security":"Common Stock","published_at":"2023-02-02T19:49:55.000Z","date":"2023-02-01","kind":"purchase","acquired":true,"shares":400,"price":3.1034,"value":1241.36,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $3.07 to $3.12 per share.  The price reported above reflects the weighted average purchase price.  The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 99,899 shares received pursuant to an unvested restricted stock unit grant. Such shares vest to the extent of 1,037 shares on February 18, 2023, 49,949 shares on March 18, 2023 and 48,913 shares on March 18, 2024."}],"balance_after":187321,"source":{"system":"sec-edgar","filing":"0001567619-23-001697","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761923001697/doc1.xml","form_type":"4"}},{"id":2041910,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, COB"}}],"security":"Common Stock","published_at":"2023-01-30T14:33:11.000Z","date":"2023-01-27","kind":"purchase","acquired":true,"shares":200,"price":3.01,"value":602.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 99,899 shares received pursuant to an unvested restricted stock unit grant. Such shares vest to the extent of 1,037 shares on February 18, 2023, 49,949 shares on March 18, 2023 and 48,913 shares on March 18, 2024."}],"balance_after":186921,"source":{"system":"sec-edgar","filing":"0001567619-23-001399","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761923001399/doc1.xml","form_type":"4"}},{"id":2047286,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, COB"}}],"security":"Common Stock","published_at":"2023-01-24T17:27:29.000Z","date":"2023-01-20","kind":"purchase","acquired":true,"shares":100,"price":3.17,"value":317.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 99,899 shares received pursuant to an unvested restricted stock unit grant. Such shares vest to the extent of 1,037 shares on February 18, 2023, 49,949 shares on March 18, 2023 and 48,913 shares on March 18, 2024."}],"balance_after":186721,"source":{"system":"sec-edgar","filing":"0001567619-23-001186","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761923001186/doc1.xml","form_type":"4"}},{"id":2047285,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, COB"}}],"security":"Common Stock","published_at":"2023-01-24T17:27:29.000Z","date":"2023-01-20","kind":"purchase","acquired":true,"shares":100,"price":3.1,"value":310.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 99,899 shares received pursuant to an unvested restricted stock unit grant. Such shares vest to the extent of 1,037 shares on February 18, 2023, 49,949 shares on March 18, 2023 and 48,913 shares on March 18, 2024."}],"balance_after":186621,"source":{"system":"sec-edgar","filing":"0001567619-23-001186","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761923001186/doc1.xml","form_type":"4"}},{"id":2049444,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, COB"}}],"security":"Common Stock","published_at":"2023-01-20T13:19:54.000Z","date":"2023-01-18","kind":"purchase","acquired":true,"shares":100,"price":3.087,"value":308.7,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 99,899 shares received pursuant to an unvested restricted stock unit grant. Such shares vest to the extent of 1,037 shares on February 18, 2023, 49,949 shares on March 18, 2023 and 48,913 shares on March 18, 2024."}],"balance_after":186521,"source":{"system":"sec-edgar","filing":"0001567619-23-001056","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761923001056/doc1.xml","form_type":"4"}},{"id":2049443,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, COB"}}],"security":"Common Stock","published_at":"2023-01-20T13:19:54.000Z","date":"2023-01-18","kind":"purchase","acquired":true,"shares":100,"price":3.096,"value":309.6,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 99,899 shares received pursuant to an unvested restricted stock unit grant. Such shares vest to the extent of 1,037 shares on February 18, 2023, 49,949 shares on March 18, 2023 and 48,913 shares on March 18, 2024."}],"balance_after":186421,"source":{"system":"sec-edgar","filing":"0001567619-23-001056","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761923001056/doc1.xml","form_type":"4"}},{"id":2049442,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, COB"}}],"security":"Common Stock","published_at":"2023-01-20T13:19:54.000Z","date":"2023-01-18","kind":"purchase","acquired":true,"shares":200,"price":3.13,"value":626.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 99,899 shares received pursuant to an unvested restricted stock unit grant. Such shares vest to the extent of 1,037 shares on February 18, 2023, 49,949 shares on March 18, 2023 and 48,913 shares on March 18, 2024."}],"balance_after":186321,"source":{"system":"sec-edgar","filing":"0001567619-23-001056","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761923001056/doc1.xml","form_type":"4"}},{"id":2057302,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, COB"}}],"security":"Common Stock","published_at":"2023-01-10T23:06:50.000Z","date":"2023-01-09","kind":"purchase","acquired":true,"shares":100,"price":3.08,"value":308.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Includes 100,935 shares received pursuant to an unvested restricted stock unit grant. Such shares vest to the extent of 1,036 shares on January 18, 2023, 1,037 shares on February 18, 2023, 49,949 shares on March 18, 2023 and 48,913 shares on March 18, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 100,935 shares received pursuant to an unvested restricted stock unit grant. Such shares vest to the extent of 1,036 shares on January 18, 2023, 1,037 shares on February 18, 2023, 49,949 shares on March 18, 2023 and 48,913 shares on March 18, 2024."}],"balance_after":186121,"source":{"system":"sec-edgar","filing":"0001567619-23-000770","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761923000770/doc1.xml","form_type":"4"}},{"id":2075432,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, COB"}}],"security":"Common Stock","published_at":"2022-12-28T13:22:56.000Z","date":"2022-12-23","kind":"purchase","acquired":true,"shares":100,"price":2.99,"value":299.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 100,935 shares received pursuant to an unvested restricted stock unit grant. Such shares vest to the extent of 1,036 shares on January 18, 2023, 1,037 shares on February 18, 2023, 49,949 shares on March 18, 2023 and 48,913 shares on March 18, 2024."}],"balance_after":186021,"source":{"system":"sec-edgar","filing":"0001567619-22-022055","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761922022055/doc1.xml","form_type":"4"}},{"id":2075431,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, COB"}}],"security":"Common Stock","published_at":"2022-12-28T13:22:56.000Z","date":"2022-12-23","kind":"purchase","acquired":true,"shares":200,"price":3.02,"value":604.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 100,935 shares received pursuant to an unvested restricted stock unit grant. Such shares vest to the extent of 1,036 shares on January 18, 2023, 1,037 shares on February 18, 2023, 49,949 shares on March 18, 2023 and 48,913 shares on March 18, 2024."}],"balance_after":185921,"source":{"system":"sec-edgar","filing":"0001567619-22-022055","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761922022055/doc1.xml","form_type":"4"}},{"id":2093052,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, COB"}}],"security":"Common Stock","published_at":"2022-12-07T23:04:51.000Z","date":"2022-12-07","kind":"purchase","acquired":true,"shares":1800,"price":2.9861,"value":5374.98,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $2.93 to $3.00 per share.  The price reported above reflects the weighted average purchase price.  The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 101,972 shares received pursuant to an unvested restricted stock unit grant. Such shares vest to the extent of 1,037 shares on December 18, 2022 and February 18, 2023, 1,036 shares on January 18, 2023, 49,949 shares on March 18, 2023 and 48,913 shares on March 18, 2024."}],"balance_after":185721,"source":{"system":"sec-edgar","filing":"0001567619-22-021408","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761922021408/doc1.xml","form_type":"4"}},{"id":2108256,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, COB"}}],"security":"Common Stock","published_at":"2022-11-21T12:49:04.000Z","date":"2022-11-18","kind":"purchase","acquired":true,"shares":1000,"price":2.8765,"value":2876.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $2.80 to $2.97 per share.  The price reported above reflects the weighted average purchase price.  The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 101,972 shares received pursuant to an unvested restricted stock unit grant. Such shares vest to the extent of 1,037 shares on December 18, 2022 and February 18, 2023, 1,036 shares on January 18, 2023, 49,949 shares on March 18, 2023 and 48,913 shares on March 18, 2024."}],"balance_after":183921,"source":{"system":"sec-edgar","filing":"0001567619-22-020651","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761922020651/doc1.xml","form_type":"4"}},{"id":2124210,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, COB"}}],"security":"Stock Option","published_at":"2022-11-04T20:16:09.000Z","date":"2022-11-03","kind":"grant","acquired":true,"shares":42059,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the \"old\" stock option and the grant of a \"replacement\" stock option with a reduced exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable to the extent of 21,030 shares on November 4, 2021 with the remaining 21,029 shares vesting quarterly in eight nearly equal installments beginning on November 4, 2022."}],"balance_after":42059,"derivative":{"exercise_price":5.08,"expiration_date":"2031-11-04","underlying":"Common Stock","underlying_shares":42059},"source":{"system":"sec-edgar","filing":"0001567619-22-019187","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761922019187/doc1.xml","form_type":"4"}},{"id":2124209,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, COB"}}],"security":"Stock Option","published_at":"2022-11-04T20:16:09.000Z","date":"2022-11-03","kind":"disposition_to_issuer","acquired":false,"shares":42059,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the \"old\" stock option and the grant of a \"replacement\" stock option with a reduced exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable to the extent of 21,030 shares on November 4, 2021 with the remaining 21,029 shares vesting quarterly in eight nearly equal installments beginning on November 4, 2022."}],"balance_after":0,"derivative":{"exercise_price":13.5,"expiration_date":"2031-11-04","underlying":"Common Stock","underlying_shares":42059},"source":{"system":"sec-edgar","filing":"0001567619-22-019187","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761922019187/doc1.xml","form_type":"4"}},{"id":2124208,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, COB"}}],"security":"Stock Option","published_at":"2022-11-04T20:16:09.000Z","date":"2022-11-03","kind":"grant","acquired":true,"shares":293479,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the \"old\" stock option and the grant of a \"replacement\" stock option with a reduced exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable to the extent of 146,740 shares on March 18, 2021, 36,684 shares on November 4, 2021 with the remaining 110,055 shares in six nearly equal quarterly installments beginning December 18, 2021 and continuing every three months thereafter until fully vested."}],"balance_after":293479,"derivative":{"exercise_price":5.08,"expiration_date":"2031-03-18","underlying":"Common Stock","underlying_shares":293479},"source":{"system":"sec-edgar","filing":"0001567619-22-019187","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761922019187/doc1.xml","form_type":"4"}},{"id":2124207,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, COB"}}],"security":"Stock Option","published_at":"2022-11-04T20:16:09.000Z","date":"2022-11-03","kind":"disposition_to_issuer","acquired":false,"shares":293479,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the \"old\" stock option and the grant of a \"replacement\" stock option with a reduced exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable to the extent of 146,740 shares on March 18, 2021, 36,684 shares on November 4, 2021 with the remaining 110,055 shares in six nearly equal quarterly installments beginning December 18, 2021 and continuing every three months thereafter until fully vested."}],"balance_after":0,"derivative":{"exercise_price":13.5,"expiration_date":"2031-03-18","underlying":"Common Stock","underlying_shares":293479},"source":{"system":"sec-edgar","filing":"0001567619-22-019187","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761922019187/doc1.xml","form_type":"4"}},{"id":2151786,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, COB"}}],"security":"Common Stock","published_at":"2022-09-23T13:55:27.000Z","date":"2022-09-22","kind":"purchase","acquired":true,"shares":100,"price":2.85,"value":285.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 104,045 shares received pursuant to unvested restricted stock unit grants. Such shares vest to the extent of 1,037 shares on October 18, 2022, December 18, 2022 and February 18, 2023, 1,036 shares on November 18, 2022 and January 18, 2023, 49,949 shares on March 18, 2023 and 48,913 shares on March 18, 2024."}],"balance_after":182921,"source":{"system":"sec-edgar","filing":"0001567619-22-017754","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761922017754/doc1.xml","form_type":"4"}},{"id":2151785,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, COB"}}],"security":"Common Stock","published_at":"2022-09-23T13:55:27.000Z","date":"2022-09-22","kind":"purchase","acquired":true,"shares":100,"price":2.99,"value":299.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 104,045 shares received pursuant to unvested restricted stock unit grants. Such shares vest to the extent of 1,037 shares on October 18, 2022, December 18, 2022 and February 18, 2023, 1,036 shares on November 18, 2022 and January 18, 2023, 49,949 shares on March 18, 2023 and 48,913 shares on March 18, 2024."}],"balance_after":182821,"source":{"system":"sec-edgar","filing":"0001567619-22-017754","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761922017754/doc1.xml","form_type":"4"}},{"id":2207945,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, COB"}}],"security":"Common Stock","published_at":"2022-07-13T12:25:40.000Z","date":"2022-07-12","kind":"purchase","acquired":true,"shares":700,"price":2.95,"value":2065.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $2.90 to $2.97 per share.  The price reported above reflects the weighted average purchase price.  The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 107,154 shares received pursuant to unvested restricted stock unit grants. Such shares vest to the extent of 1,037 shares on August 18, 2022, October 18, 2022, December 18, 2022 and February 18, 2023, 1,036 shares on July 18, 2022, September 18, 2022, November 18, 2022 and January 18, 2023, 49,949 shares on March 18, 2023 and 48,913 shares on March 18, 2024."}],"balance_after":182721,"source":{"system":"sec-edgar","filing":"0001567619-22-013928","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761922013928/doc1.xml","form_type":"4"}},{"id":2216782,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, COB"}}],"security":"Common Stock","published_at":"2022-07-01T13:20:25.000Z","date":"2022-06-30","kind":"purchase","acquired":true,"shares":1100,"price":3.0981,"value":3407.91,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $3.03 to $3.1499 per share.  The price reported above reflects the weighted average purchase price.  The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 107,154 shares received pursuant to unvested restricted stock unit grants. Such shares vest to the extent of 1,037 shares on August 18, 2022, October 18, 2022, December 18, 2022 and February 18, 2023, 1,036 shares on July 18, 2022, September 18, 2022, November 18, 2022 and January 18, 2023, 49,949 shares on March 18, 2023 and 48,913 shares on March 18, 2024."}],"balance_after":182021,"source":{"system":"sec-edgar","filing":"0001567619-22-013553","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761922013553/doc1.xml","form_type":"4"}},{"id":2227044,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, COB"}}],"security":"Common Stock","published_at":"2022-06-17T20:02:19.000Z","date":"2022-06-16","kind":"purchase","acquired":true,"shares":600,"price":3.73,"value":2238.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $3.57 to $3.86 per share.  The price reported above reflects the weighted average purchase price.  The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 108,191 shares received pursuant to unvested restricted stock unit grants. Such shares vest to the extent of 1,037 shares on June 18, 2022, August 18, 2022, October 18, 2022, December 18, 2022 and February 18, 2023, 1,036 shares on July 18, 2022, September 18, 2022, November 18, 2022 and January 18, 2023, 49,949 shares on March 18, 2023 and 48,913 shares on March 18, 2024."}],"balance_after":180921,"source":{"system":"sec-edgar","filing":"0001567619-22-013067","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761922013067/doc1.xml","form_type":"4"}},{"id":2231149,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, COB"}}],"security":"Common Stock","published_at":"2022-06-15T21:30:55.000Z","date":"2022-06-15","kind":"purchase","acquired":true,"shares":700,"price":3.6822,"value":2577.54,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $3.655 to $3.7167 per share.  The price reported above reflects the weighted average purchase price.  The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 108,191 shares received pursuant to unvested restricted stock unit grants. Such shares vest to the extent of 1,037 shares on June 18, 2022, August 18, 2022, October 18, 2022, December 18, 2022 and February 18, 2023, 1,036 shares on July 18, 2022, September 18, 2022, November 18, 2022 and January 18, 2023, 49,949 shares on March 18, 2023 and 48,913 shares on March 18, 2024."}],"balance_after":180321,"source":{"system":"sec-edgar","filing":"0001567619-22-012910","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761922012910/doc1.xml","form_type":"4"}},{"id":2231146,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, COB"}}],"security":"Common Stock","published_at":"2022-06-15T15:01:53.000Z","date":"2022-06-14","kind":"purchase","acquired":true,"shares":500,"price":3.9119,"value":1955.95,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $3.8499 to $3.9699 per share.  The price reported above reflects the weighted average purchase price.  The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 108,191 shares received pursuant to unvested restricted stock unit grants. Such shares vest to the extent of 1,037 shares on June 18, 2022, August 18, 2022, October 18, 2022, December 18, 2022 and February 18, 2023, 1,036 shares on July 18, 2022, September 18, 2022, November 18, 2022 and January 18, 2023, 49,949 shares on March 18, 2023 and 48,913 shares on March 18, 2024."}],"balance_after":179621,"source":{"system":"sec-edgar","filing":"0001567619-22-012867","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761922012867/doc1.xml","form_type":"4"}},{"id":2232304,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, COB"}}],"security":"Common Stock","published_at":"2022-06-14T15:55:53.000Z","date":"2022-06-13","kind":"purchase","acquired":true,"shares":100,"price":3.92,"value":392.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 108,191 shares received pursuant to unvested restricted stock unit grants. Such shares vest to the extent of 1,037 shares on June 18, 2022, August 18, 2022, October 18, 2022, December 18, 2022 and February 18, 2023, 1,036 shares on July 18, 2022, September 18, 2022, November 18, 2022 and January 18, 2023, 49,949 shares on March 18, 2023 and 48,913 shares on March 18, 2024."}],"balance_after":179121,"source":{"system":"sec-edgar","filing":"0001567619-22-012812","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761922012812/doc1.xml","form_type":"4"}},{"id":2232303,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, COB"}}],"security":"Common Stock","published_at":"2022-06-14T15:55:53.000Z","date":"2022-06-13","kind":"purchase","acquired":true,"shares":100,"price":3.98,"value":398.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 108,191 shares received pursuant to unvested restricted stock unit grants. Such shares vest to the extent of 1,037 shares on June 18, 2022, August 18, 2022, October 18, 2022, December 18, 2022 and February 18, 2023, 1,036 shares on July 18, 2022, September 18, 2022, November 18, 2022 and January 18, 2023, 49,949 shares on March 18, 2023 and 48,913 shares on March 18, 2024."}],"balance_after":179021,"source":{"system":"sec-edgar","filing":"0001567619-22-012812","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761922012812/doc1.xml","form_type":"4"}},{"id":2237353,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, COB"}}],"security":"Common Stock","published_at":"2022-06-09T15:41:50.000Z","date":"2022-06-08","kind":"purchase","acquired":true,"shares":100,"price":4.28,"value":428.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 108,191 shares received pursuant to unvested restricted stock unit grants. Such shares vest to the extent of 1,037 shares on June 18, 2022, August 18, 2022, October 18, 2022, December 18, 2022 and February 18, 2023, 1,036 shares on July 18, 2022, September 18, 2022, November 18, 2022 and January 18, 2023, 49,949 shares on March 18, 2023 and 48,913 shares on March 18, 2024."}],"balance_after":178921,"source":{"system":"sec-edgar","filing":"0001567619-22-012581","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761922012581/doc1.xml","form_type":"4"}},{"id":2243898,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, COB"}}],"security":"Common Stock","published_at":"2022-06-03T10:58:25.000Z","date":"2022-06-01","kind":"purchase","acquired":true,"shares":200,"price":4.6,"value":920.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 108,191 shares received pursuant to unvested restricted stock unit grants. Such shares vest to the extent of 1,037 shares on June 18, 2022, August 18, 2022, October 18, 2022, December 18, 2022 and February 18, 2023, 1,036 shares on July 18, 2022, September 18, 2022, November 18, 2022 and January 18, 2023, 49,949 shares on March 18, 2023 and 48,913 shares on March 18, 2024."}],"balance_after":178821,"source":{"system":"sec-edgar","filing":"0001567619-22-012211","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761922012211/doc1.xml","form_type":"4"}},{"id":2252910,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, COB"}}],"security":"Common Stock","published_at":"2022-05-27T14:23:27.000Z","date":"2022-05-26","kind":"purchase","acquired":true,"shares":2700,"price":3.5163,"value":9494.01,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $3.4347 to $3.5499 per share.  The price reported above reflects the weighted average purchase price.  The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 108,191 shares received pursuant to unvested restricted stock unit grants. Such shares vest to the extent of 1,037 shares on June 18, 2022, August 18, 2022, October 18, 2022, December 18, 2022 and February 18, 2023, 1,036 shares on July 18, 2022, September 18, 2022, November 18, 2022 and January 18, 2023, 49,949 shares on March 18, 2023 and 48,913 shares on March 18, 2024."}],"balance_after":178621,"source":{"system":"sec-edgar","filing":"0001567619-22-011807","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761922011807/doc1.xml","form_type":"4"}},{"id":2286207,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, COB"}}],"security":"Common Stock","published_at":"2022-05-02T21:14:44.000Z","date":"2022-05-02","kind":"purchase","acquired":true,"shares":200,"price":3.959,"value":791.8,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 109,227 shares received pursuant to unvested restricted stock unit grants. Such shares vest to the extent of 1,037 shares beginning on May 18, 2022 and continuing monthly through September 18, 2022, 1,036 shares beginning on October 18, 2022 and continuing monthly through February 18, 2023, 49,949 shares on March 18, 2023 and 48,913 shares on March 18, 2024."}],"balance_after":175921,"source":{"system":"sec-edgar","filing":"0001567619-22-009300","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761922009300/doc1.xml","form_type":"4"}},{"id":2286206,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, COB"}}],"security":"Common Stock","published_at":"2022-05-02T21:14:44.000Z","date":"2022-05-02","kind":"purchase","acquired":true,"shares":200,"price":3.935,"value":787.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 109,227 shares received pursuant to unvested restricted stock unit grants. Such shares vest to the extent of 1,037 shares beginning on May 18, 2022 and continuing monthly through September 18, 2022, 1,036 shares beginning on October 18, 2022 and continuing monthly through February 18, 2023, 49,949 shares on March 18, 2023 and 48,913 shares on March 18, 2024."}],"balance_after":175721,"source":{"system":"sec-edgar","filing":"0001567619-22-009300","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761922009300/doc1.xml","form_type":"4"}},{"id":2320881,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, COB"}}],"security":"Common Stock","published_at":"2022-03-22T21:08:37.000Z","date":"2022-03-18","kind":"grant","acquired":true,"shares":12438,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares received pursuant to a restricted stock unit grant.  Vests in twelve nearly equal monthly installments beginning April 18, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 110,264 shares received pursuant to unvested restricted stock unit grants. Such shares vest to the extent of 1,037 shares beginning on April 18, 2022 and continuing monthly through September 18, 2022, 1,036 shares beginning on October 18, 2022 and continuing monthly through February 18, 2023, 49,949 shares on March 18, 2023 and 48,913 shares on March 18, 2024."}],"balance_after":175521,"source":{"system":"sec-edgar","filing":"0001567619-22-007347","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761922007347/doc1.xml","form_type":"4"}},{"id":2427461,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, COB"}}],"security":"Common Stock","published_at":"2022-01-24T22:03:47.000Z","date":"2022-01-24","kind":"purchase","acquired":true,"shares":1470,"price":3.4,"value":4998.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 146,740 shares received pursuant to an unvested restricted stock unit grant. Such shares vest to the extent of 48,914 shares on March 18, 2022 and 48,913 shares on each of March 18, 2023 and March 18, 2024."}],"balance_after":163083,"source":{"system":"sec-edgar","filing":"0001567619-22-001588","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761922001588/doc1.xml","form_type":"4"}},{"id":2442964,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, COB"}}],"security":"Common Stock","published_at":"2022-01-05T21:52:32.000Z","date":"2022-01-05","kind":"purchase","acquired":true,"shares":2000,"price":3.85,"value":7700.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 146,740 shares received pursuant to an unvested restricted stock unit grant. Such shares vest to the extent of 48,914 shares on March 18, 2022 and 48,913 shares on each of March 18, 2023 and March 18, 2024."}],"balance_after":161613,"source":{"system":"sec-edgar","filing":"0001567619-22-000585","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761922000585/doc1.xml","form_type":"4"}},{"id":2488196,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, COB"}}],"security":"Common Stock","published_at":"2021-12-02T15:00:21.000Z","date":"2021-12-01","kind":"purchase","acquired":true,"shares":799,"price":5.5,"value":4394.5,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 146,740 shares received pursuant to an unvested restricted stock unit grant. Such shares vest to the extent of 48,914 shares on March 18, 2022 and 48,913 shares on each of March 18, 2023 and March 18, 2024."}],"balance_after":159613,"source":{"system":"sec-edgar","filing":"0001567619-21-021415","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761921021415/doc1.xml","form_type":"4"}},{"id":2497252,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, COB"}}],"security":"Common Stock","published_at":"2021-11-23T22:15:27.000Z","date":"2021-11-23","kind":"purchase","acquired":true,"shares":2500,"price":6,"value":15000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 146,740 shares received pursuant to an unvested restricted stock unit grant. Such shares vest to the extent of 48,914 shares on March 18, 2022 and 48,913 shares on each of March 18, 2023 and March 18, 2024."}],"balance_after":158814,"source":{"system":"sec-edgar","filing":"0001567619-21-021072","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761921021072/doc1.xml","form_type":"4"}},{"id":2500185,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, COB"}}],"security":"Common Stock","published_at":"2021-11-22T22:29:40.000Z","date":"2021-11-22","kind":"purchase","acquired":true,"shares":396,"price":6.31,"value":2498.76,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 146,740 shares received pursuant to an unvested restricted stock unit grant. Such shares vest to the extent of 48,914 shares on March 18, 2022 and 48,913 shares on each of March 18, 2023 and March 18, 2024."}],"balance_after":156314,"source":{"system":"sec-edgar","filing":"0001567619-21-020992","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761921020992/doc1.xml","form_type":"4"}},{"id":2510096,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, COB"}}],"security":"Common Stock","published_at":"2021-11-16T23:07:03.000Z","date":"2021-11-16","kind":"purchase","acquired":true,"shares":1500,"price":6.51,"value":9765.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 146,740 shares received pursuant to an unvested restricted stock unit grant. Such shares vest to the extent of 48,914 shares on March 18, 2022 and 48,913 shares on each of March 18, 2023 and March 18, 2024."}],"balance_after":155918,"source":{"system":"sec-edgar","filing":"0001567619-21-020595","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761921020595/doc1.xml","form_type":"4"}},{"id":2510095,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, COB"}}],"security":"Common Stock","published_at":"2021-11-16T23:07:03.000Z","date":"2021-11-16","kind":"purchase","acquired":true,"shares":200,"price":6.55,"value":1310.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 146,740 shares received pursuant to an unvested restricted stock unit grant. Such shares vest to the extent of 48,914 shares on March 18, 2022 and 48,913 shares on each of March 18, 2023 and March 18, 2024."}],"balance_after":154418,"source":{"system":"sec-edgar","filing":"0001567619-21-020595","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761921020595/doc1.xml","form_type":"4"}},{"id":2510094,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, COB"}}],"security":"Common Stock","published_at":"2021-11-16T23:07:03.000Z","date":"2021-11-16","kind":"purchase","acquired":true,"shares":1800,"price":6.87,"value":12366.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 146,740 shares received pursuant to an unvested restricted stock unit grant. Such shares vest to the extent of 48,914 shares on March 18, 2022 and 48,913 shares on each of March 18, 2023 and March 18, 2024."}],"balance_after":154218,"source":{"system":"sec-edgar","filing":"0001567619-21-020595","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761921020595/doc1.xml","form_type":"4"}},{"id":2510093,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, COB"}}],"security":"Common Stock","published_at":"2021-11-16T23:07:03.000Z","date":"2021-11-16","kind":"purchase","acquired":true,"shares":1000,"price":6.76,"value":6760.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $6.74 to $6.77, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 146,740 shares received pursuant to an unvested restricted stock unit grant. Such shares vest to the extent of 48,914 shares on March 18, 2022 and 48,913 shares on each of March 18, 2023 and March 18, 2024."}],"balance_after":152418,"source":{"system":"sec-edgar","filing":"0001567619-21-020595","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761921020595/doc1.xml","form_type":"4"}},{"id":2521121,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, COB"}}],"security":"Stock Option","published_at":"2021-11-08T22:30:20.000Z","date":"2021-11-04","kind":"grant","acquired":true,"shares":42059,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option vests and becomes exercisable to the extent of 21,030 shares on November 4, 2021 with the remaining 21,029 shares vesting quarterly in eight nearly equal installments beginning on November 4, 2022."}],"balance_after":42059,"derivative":{"exercise_price":13.5,"expiration_date":"2031-11-04","underlying":"Common Stock","underlying_shares":42059},"source":{"system":"sec-edgar","filing":"0001567619-21-019494","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761921019494/doc1.xml","form_type":"4"}},{"id":2521120,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, COB"}}],"security":"Stock Option","published_at":"2021-11-08T22:30:20.000Z","date":"2021-11-04","kind":"grant","acquired":true,"shares":293479,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the \"old\" stock option and the grant of a \"replacement\" stock option with an adjusted exercise price and vesting dates."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests and becomes exercisable to the extent of 146,740 shares on March 18, 2021, 36,684 shares on November 4, 2021 with the remaining 110,055 shares in six nearly equal quarterly installments beginning December 18, 2021 and continuing every three months thereafter until fully vested."}],"balance_after":293479,"derivative":{"exercise_price":13.5,"expiration_date":"2031-03-18","underlying":"Common Stock","underlying_shares":293479},"source":{"system":"sec-edgar","filing":"0001567619-21-019494","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761921019494/doc1.xml","form_type":"4"}},{"id":2521119,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, COB"}}],"security":"Stock Option","published_at":"2021-11-08T22:30:20.000Z","date":"2021-11-04","kind":"disposition_to_issuer","acquired":false,"shares":293479,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Reflects a 1-for-4,000 reverse split effected by the issuer on October 27, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the \"old\" stock option and the grant of a \"replacement\" stock option with an adjusted exercise price and vesting dates."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests to the extent of 146,740 shares on March 18, 2021, 73,370 shares on March 18, 2022 and 73,369 shares on March 18, 2023."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Reflects a 1-for-4,000 reverse split effected by the issuer on October 27, 2021."}],"balance_after":0,"derivative":{"exercise_price":47.6,"expiration_date":"2031-03-18","underlying":"Common Stock","underlying_shares":293479},"source":{"system":"sec-edgar","filing":"0001567619-21-019494","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761921019494/doc1.xml","form_type":"4"}},{"id":2777296,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President, CEO, COB"}}],"security":"Stock Option","published_at":"2021-03-19T21:03:21.000Z","date":"2021-03-18","kind":"grant","acquired":true,"shares":1173917974,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Such shares vest to the extent of 586,958,987 shares on the date of grant, 293,479,494 shares on March 18, 2022 and 293,479,493 shares on March 18, 2023."}],"balance_after":1173917974,"derivative":{"exercise_price":0.0119,"expiration_date":"2031-03-18","underlying":"Common Stock","underlying_shares":1173917974},"source":{"system":"sec-edgar","filing":"0001567619-21-006690","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761921006690/doc1.xml","form_type":"4"}},{"id":2777295,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President, CEO, COB"}}],"security":"Common Stock","published_at":"2021-03-19T21:03:21.000Z","date":"2021-03-18","kind":"grant","acquired":true,"shares":586958987,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares received pursuant to a restricted stock unit grant. Vests in three nearly equal annual installments beginning March 18, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 586,958,987 shares received pursuant to an unvested restricted stock unit grant. Such shares vest to the extent of 195,652,996 shares on each of March 18, 2022 and March 18, 2023 and 195,652,995 shares on March 18, 2024."}],"balance_after":605670653,"source":{"system":"sec-edgar","filing":"0001567619-21-006690","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761921006690/doc1.xml","form_type":"4"}},{"id":2967591,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, COB"}}],"security":"Common Stock","published_at":"2020-11-24T21:11:43.000Z","date":"2020-11-23","kind":"other","acquired":true,"shares":18661666,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares acquired from Issuer pursuant to amended joint plan of reorganization of Issuer (the \"Plan\").  Pursuant to the Plan, 100 shares of common stock were issued for each dollar of allowed unsecured claim."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares acquired from Issuer pursuant to amended joint plan of reorganization of Issuer (the \"Plan\").  Pursuant to the Plan, 100 shares of common stock were issued for each dollar of allowed unsecured claim."}],"balance_after":18711666,"source":{"system":"sec-edgar","filing":"0001567619-20-020268","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761920020268/doc1.xml","form_type":"4"}},{"id":3418342,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Strategy Officer"}}],"security":"Common Stock","published_at":"2019-09-10T21:01:33.000Z","date":"2019-09-09","kind":"purchase","acquired":true,"shares":14900,"price":0.27,"value":4023.0,"ownership":{"direct":true},"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001567619-19-018128","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761919018128/doc1.xml","form_type":"4"}},{"id":3418341,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Strategy Officer"}}],"security":"Common Stock","published_at":"2019-09-10T21:01:33.000Z","date":"2019-09-09","kind":"purchase","acquired":true,"shares":2500,"price":0.24,"value":600.0,"ownership":{"direct":true},"balance_after":35100,"source":{"system":"sec-edgar","filing":"0001567619-19-018128","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761919018128/doc1.xml","form_type":"4"}},{"id":3418340,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Strategy Officer"}}],"security":"Common Stock","published_at":"2019-09-10T21:01:33.000Z","date":"2019-09-09","kind":"purchase","acquired":true,"shares":2500,"price":0.23,"value":575.0,"ownership":{"direct":true},"balance_after":32600,"source":{"system":"sec-edgar","filing":"0001567619-19-018128","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761919018128/doc1.xml","form_type":"4"}},{"id":3418339,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Strategy Officer"}}],"security":"Common Stock","published_at":"2019-09-10T21:01:33.000Z","date":"2019-09-09","kind":"purchase","acquired":true,"shares":100,"price":0.22,"value":22.0,"ownership":{"direct":true},"balance_after":30100,"source":{"system":"sec-edgar","filing":"0001567619-19-018128","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761919018128/doc1.xml","form_type":"4"}},{"id":3420287,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Strategy Officer"}}],"security":"Common Stock","published_at":"2019-09-06T21:05:57.000Z","date":"2019-09-05","kind":"purchase","acquired":true,"shares":9900,"price":0.2699,"value":2672.01,"ownership":{"direct":true},"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001567619-19-018008","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761919018008/doc1.xml","form_type":"4"}},{"id":3420286,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Strategy Officer"}}],"security":"Common Stock","published_at":"2019-09-06T21:05:57.000Z","date":"2019-09-05","kind":"purchase","acquired":true,"shares":100,"price":0.2549,"value":25.49,"ownership":{"direct":true},"balance_after":20100,"source":{"system":"sec-edgar","filing":"0001567619-19-018008","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761919018008/doc1.xml","form_type":"4"}},{"id":3427907,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Strategy Officer"}}],"security":"Common Stock","published_at":"2019-08-27T21:23:12.000Z","date":"2019-08-27","kind":"purchase","acquired":true,"shares":6200,"price":0.28,"value":1736.0,"ownership":{"direct":true},"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001567619-19-017607","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761919017607/doc1.xml","form_type":"4"}},{"id":3427906,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Strategy Officer"}}],"security":"Common Stock","published_at":"2019-08-27T21:23:12.000Z","date":"2019-08-27","kind":"purchase","acquired":true,"shares":3700,"price":0.27,"value":999.0,"ownership":{"direct":true},"balance_after":13800,"source":{"system":"sec-edgar","filing":"0001567619-19-017607","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761919017607/doc1.xml","form_type":"4"}},{"id":3427905,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Strategy Officer"}}],"security":"Common Stock","published_at":"2019-08-27T21:23:12.000Z","date":"2019-08-27","kind":"purchase","acquired":true,"shares":100,"price":0.26,"value":26.0,"ownership":{"direct":true},"balance_after":10100,"source":{"system":"sec-edgar","filing":"0001567619-19-017607","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761919017607/doc1.xml","form_type":"4"}},{"id":3430823,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Strategy Officer"}}],"security":"Common Stock","published_at":"2019-08-22T22:01:52.000Z","date":"2019-08-21","kind":"purchase","acquired":true,"shares":9900,"price":0.25,"value":2475.0,"ownership":{"direct":true},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001567619-19-017492","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761919017492/doc1.xml","form_type":"4"}},{"id":3430822,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Strategy Officer"}}],"security":"Common Stock","published_at":"2019-08-22T22:01:52.000Z","date":"2019-08-21","kind":"purchase","acquired":true,"shares":100,"price":0.23,"value":23.0,"ownership":{"direct":true},"balance_after":100,"source":{"system":"sec-edgar","filing":"0001567619-19-017492","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761919017492/doc1.xml","form_type":"4"}},{"id":3578152,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Strategy Officer"}}],"security":"Stock Option","published_at":"2019-03-26T21:19:03.000Z","date":"2019-03-25","kind":"grant","acquired":true,"shares":500000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported transaction involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the \"old\" stock option and the grant of a \"replacement\" stock option at a reduced exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests to the extent of 100,000 shares as of October 15, 2018, 150,000 shares upon the earlier of October 15, 2019 or the date on which the initial patient recruitment for the Company's Phase II lumbar clinical trial occurs, and 250,000 shares as of October 15, 2020."}],"balance_after":500000,"derivative":{"exercise_price":0.75,"expiration_date":"2028-10-15","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001567619-19-007660","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761919007660/doc1.xml","form_type":"4"}},{"id":3578151,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Strategy Officer"}}],"security":"Stock Option","published_at":"2019-03-26T21:19:03.000Z","date":"2019-03-25","kind":"disposition_to_issuer","acquired":false,"shares":500000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported transaction involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the \"old\" stock option and the grant of a \"replacement\" stock option at a reduced exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests to the extent of 100,000 shares as of October 15, 2018, 150,000 shares upon the earlier of October 15, 2019 or the date on which the initial patient recruitment for the Company's Phase II lumbar clinical trial occurs, and 250,000 shares as of October 15, 2020."}],"balance_after":0,"derivative":{"exercise_price":1.42,"expiration_date":"2028-10-15","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001567619-19-007660","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761919007660/doc1.xml","form_type":"4"}},{"id":3787943,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Strategy Officer"}}],"security":"Stock Option","published_at":"2018-10-17T20:47:26.000Z","date":"2018-10-15","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests to the extent of 100,000 shares as of October 15, 2018, 150,000 shares upon the earlier of October 15, 2019 or the date on which the initial patient recruitment for the Company's Phase II lumbar clinical trial occurs, and 250,000 shares as of October 15, 2020."}],"balance_after":500000,"derivative":{"exercise_price":1.42,"expiration_date":"2028-10-15","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001567619-18-004233","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761918004233/doc1.xml","form_type":"4"}}]}